-
IFPMA’s new code bans all gifts – no exceptions!
pharmaphorum
January 15, 2019
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has published its new code of practice, introducing a total ban on gifts and promotional items for prescription drugs for the first time.
-
Takeda unlikely to sell OTC unit to pay Shire merger debts
pharmaphorum
January 08, 2019
Takeda’s $59 billion takeover of Shire is due to close tomorrow (Tuesday) and the company’s CEO Christophe Weber has already given some strong clues about the company’s strategy once the deal completes.
-
Bristol-Myers Squibb nears $1.6B sale of OTC unit Upsa to Taisho: report
fiercepharma
January 03, 2019
Amid an industrywide shift away from the sector, Bristol-Myers Squibb is close to becoming the latest Big Pharma to exit consumer health. And word is Japan’s Taisho will be the one to help the company do it.
-
Bristol-Myers Squibb nears $1.6B sale of OTC unit Upsa to Taisho: report
fiercepharma
December 19, 2018
Amid an industrywide shift away from the sector, Bristol-Myers Squibb is close to becoming the latest Big Pharma to exit consumer health. And word is Japan’s Taisho will be the one to help the company do it.
-
P&G completes Merck’s Consumer Health unit acquisition for $3.8bn
pharmaceutical-technology
December 04, 2018
Procter & Gamble (P&G) has completed its acquisition of Merck’s Consumer Health business in a €3.4bn ($3.8bn) deal.The acquisition was announced in April......
-
Stada, eyeing OTC expansion, circles Bristol-Myers’ French Upsa business: report
fiercepharma
October 11, 2018
Bristol-Myers Squibb could soon find a buyer for its French consumer health business amid continuous consolidation in the sector...
-
Statement from FDA Commissioner to Improve Access to OTC Drugs
americanpharmaceuticalreview
July 24, 2018
At the FDA, we’re continuing to look at ways we can foster greater access to the medicines that help keep people healthy.
-
Thumbnail image for NHS England publishes guidelines curbing OTC prescriptions
pharmatimes
July 18, 2018
NHS England has now published guidelines that could free up to almost £100 million for frontline care every year by culling prescriptions for ‘low-value’ over the counter (OTC) medicines.
-
Bristol-Myers Squibb looks to sell French OTC unit which could bring $1.8B
fiercepharma
July 09, 2018
Add Bristol-Myers Squibb to the list of Big Pharmas doing consumer health reevaluations these days. After announcing a review last month, the U.S. drugmaker is looking to sell its French consumer health business, Upsa, according to Reuters.
-
Dongkoo Bio signs deal to sell OTC prostate drug
biospectrumasia
March 30, 2018
Cernilton treats benign prostatic hyperplasia (BPH) and chronic prostatitis.